A message from our friends at Huge Alerts

BSEM Just Released Publication of Its Audited Financial Statements for Fiscal Years 2024 and 2025—Fast-Tracking a High-Profile Nasdaq Uplisting!
BioStem Technologies (OTCQB: BSEM) is rapidly evolving from a niche regenerative medicine innovator into a full-scale MedTech growth story.
The company’s recent acquisition of BioTissue Holdings’ surgical and wound care business for up to $40 million not only broadens its market from physician offices into hospitals and surgical centers but also immediately adds $29 million in revenue and a seasoned national sales team.
Coupled with the proven BioREtain® technology and breakthrough clinical results demonstrating superior wound closure rates, BSEM is now uniquely positioned to address a $300–$350 million total addressable market.
On the financial front, BSEM continues to impress. Q4 revenue topped $10 million with nearly best-in-class gross margins of 97%, and adjusted EBITDA remained solid at $3.4 million despite temporary headwinds. Importantly, the company has published its audited 2024–2025 financials, a key milestone toward its highly anticipated Nasdaq uplisting in 2026.
This move promises increased liquidity, institutional investor interest, and higher valuation potential. With analysts assigning a $25.50 price target, BSEM’s combination of earnings strength, strategic expansion, and regulatory readiness underscores a rare small-cap investment story with multiple growth levers.
This Month’s Featured Article
SaaS Apocoplyse Survivor? Why Datadog Could Be a Real AI Winner
Written by Leo Miller. Date Posted: 3/26/2026.
Key Points
- The so-called “SaaS Apocalypse” has resulted in somewhat indiscriminate, leading to opportunities and value traps.
- As AI proliferates, Datadog could be a big beneficiary, yet shares remain down almost 40% from their highs.
- Despite the stock’s year-to-date decline, analysts see DDOG rising well above the current share price.
- Special Report: Do this before SpaceX IPOs or be sorry (From Timothy Sykes)
Over the past few months, many investors have likely encountered the phenomenon known as the “SaaS Apocalypse.” The term describes a wave of software-as-a-service (SaaS) stocks seeing their share prices plunge amid the rise of new artificial intelligence (AI) tools.
To some extent, markets have been selling off nearly every stock with even a SaaS-adjacent business model. But the impact of AI disruption will not be uniform across every SaaS company.
Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company (Ad)
We’ve found The Next Elon Musk… and what we believe to be the next Tesla.
It’s already racked up $26 billion in government contracts.
Peter Thiel just bet $1 Billion on it.👉 Unlock the ticker now and get it completely free.
This divergence can create opportunities in certain SaaS names positioned to benefitfrom AI adoption rather than be replaced by it.
One tech stock that may fit this description is Datadog (NASDAQ: DDOG). While shares have recovered from recent lows, the stock is still down roughly 10% year-to-date in 2026 and nearly 40% from its 52-week high.
Some investors believe the market may be misreading Datadog’s potential role in an AI-heavy enterprise environment.
Understanding the Drivers Behind the “SaaS Apocalypse”
One of AI’s big promises is that AI agents will be able to act autonomously within enterprise workflows.
The theory: agents will perform tasks that once required expensive SaaS products, allowing companies to significantly cut costs. That prospect is a key reason many incumbent SaaS companies have seen their shares drop sharply.
Some proponents even argue that a single highly capable employee using AI agents could replace the work of several people, reducing headcount and payroll expenses. That is the pitch from AI developers such as OpenAI, Anthropic, and Alphabet (NASDAQ: GOOGL): pay us to deploy your AI agents, and you’ll save money because you’ll need fewer employees.
But AI is still imperfect and can make mistakes, a fact visible even in consumer-facing chatbots and one that can erode trust in AI models. Inside organizations, errors can have bigger consequences—customer impact, revenue leakage, and operational disruption. As a result, businesses are unlikely to adopt AI agents at scale without first building trust and having fast ways to diagnose and fix failures. That’s one area where observability vendors argue they can help.
Outsourcing Thinking: AI Agents Increase the Need for Observability
Datadog sells observability software that collects data from companies’ applications—both internal and customer-facing—so teams can detect problems, identify root causes, and resolve incidents.
Part of the bullish case for Datadog is that while AI agents might reduce labor costs, they also introduce complexity and generate far more data.
A video on Datadog’s AI Agent Monitoring tool illustrates this. The presenter describes a fictional personal finance app called Budget Guru, where a user asks the AI agents to perform a simple task: buy $500 of a stock and remind them of their overdraft fee.
A human could complete that task in a few clicks and do the internal thinking required to execute it. Budget Guru, by contrast, coordinates five separate AI agents to carry out the request—essentially outsourcing the thinking a human would have performed. That orchestration creates a mountain of observable data about how the agents reached their decision.
AI agents produce additional logs, traces, and events that wouldn’t exist if a human handled the same task. As the number of moving parts grows, so do the potential failure points. In that context, AI agents don’t remove the need for monitoring—they raise the bar for it.
This dynamic should increase demand for observability platforms like Datadog, turning disruption risk into opportunity.
Datadog: Impressive Growth, Profitability, and Analyst Support
In its most recent quarter, Datadog’s revenues rose 29% to $953 million. The company also generated free cash flow (FCF) of $291 million, yielding an FCF margin of roughly 31%.
The Rule of 40—which combines growth and profitability to evaluate SaaS firms—is a common benchmark. Scores above 40 are generally considered healthy; Datadog’s score sits near 60.
Wall Street analysts also see upside. The MarketBeat consensus price target is near $180, implying more than 40% upside. Price targets updated after the company’s latest earnings put the average slightly lower, at about $174.
With strong growth, solid profitability, analyst backing, and potential agentic AI tailwinds, there is reason to believe DDOG could withstand—or even benefit from—the so-called “SaaS Apocalypse.”
This email is a paid advertisement sent on behalf of Huge Alerts, a third-party advertiser of MarketBeat. Why did I get this email?.
This message is a paid advertisement for BioStem Technologies Inc. (OTC: BSEM) from Sideways Frequency and Huge Alerts. American Consumer News, LLC dba MarketBeat receives a fixed fee for each subscriber that clicks on a link in this email, totaling up to $14,000. Other than the compensation received for this advertisement sent to subscribers, MarketBeat and its principals are not affiliated with either Sideways Frequency or Huge Alerts. MarketBeat and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither MarketBeat nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from MarketBeat to buy or sell any security. MarketBeat has not evaluated the accuracy of any claims made in this advertisement. MarketBeat recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding BioStem Technologies Inc. (OTC: BSEM) on Huge Alerts’ website for additional information about the relationship between Huge Alerts and BioStem Technologies Inc. (OTC: BSEM).
If you need help with your subscription, please contact our U.S. based support team at contact@marketbeat.com.
If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.
Copyright 2006-2026 MarketBeat Media, LLC. All rights reserved.
345 North Reid Place #620, Sioux Falls, SD 57103. U.S.A..
See Also: Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company(From Banyan Hill Publishing)
